SARECYCLINE HYDROCHLORIDE

SARECYCLINE HYDROCHLORIDE was reported 200 times

SARECYCLINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ATOPIC KERATOCONJUNCTIVITIS 1 0.0286
1 INFUSION SITE HYPERSENSITIVITY 1 0.0083
2 REFRACTION DISORDER 1 0.0034
3 PERIORAL DERMATITIS 2 0.0031
4 CONJUNCTIVITIS BACTERIAL 1 0.0029
5 BONE TUBERCULOSIS 1 0.0026
6 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 3 0.0022
7 WISDOM TEETH REMOVAL 2 0.0015
8 HAND DERMATITIS 1 0.0014
9 TOOTH DISCOLOURATION 4 0.0014
10 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
11 INFUSION SITE DISCOMFORT 1 0.0010
12 NASAL INFLAMMATION 1 0.0009
13 ENCEPHALITIS AUTOIMMUNE 1 0.0008
14 MAST CELL ACTIVATION SYNDROME 1 0.0007
15 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
16 ONYCHOLYSIS 1 0.0006
17 CYSTITIS INTERSTITIAL 1 0.0006
18 VEIN RUPTURE 1 0.0006
19 FOOD AVERSION 1 0.0006
20 INTRACRANIAL PRESSURE INCREASED 3 0.0005
21 OESOPHAGEAL ULCER 2 0.0005
22 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
23 PAPILLOEDEMA 2 0.0004
24 HAEMANGIOMA 1 0.0004
25 JUVENILE IDIOPATHIC ARTHRITIS 1 0.0004
26 ABNORMAL UTERINE BLEEDING 1 0.0004
27 RETINAL DISORDER 1 0.0004
28 PULMONARY PAIN 1 0.0003
29 BLADDER PAIN 1 0.0003
30 NEPHRITIS 1 0.0003
31 MOTOR DYSFUNCTION 3 0.0003
32 EUPHORIC MOOD 3 0.0003
33 DEVICE PLACEMENT ISSUE 1 0.0003
34 PARANASAL SINUS DISCOMFORT 1 0.0003
35 PHOTOSENSITIVITY REACTION 4 0.0002
36 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
37 OCULAR ICTERUS 1 0.0002
38 TOOTH INJURY 1 0.0002
39 YELLOW SKIN 1 0.0002
40 TIBIA FRACTURE 1 0.0002
41 COELIAC DISEASE 2 0.0002
42 NONSPECIFIC REACTION 1 0.0002
43 HYPERVENTILATION 1 0.0002
44 HEAD DISCOMFORT 3 0.0002
45 INFUSION SITE SWELLING 1 0.0002
46 THERAPEUTIC RESPONSE CHANGED 1 0.0002
47 SENSITIVE SKIN 1 0.0001
48 SUNBURN 1 0.0001
49 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
50 CONCUSSION 1 0.0001
51 NASAL DISCOMFORT 1 0.0001
52 LIVER INJURY 3 0.0001
53 CARDIAC MURMUR 1 0.0001
54 HIDRADENITIS 1 0.0001
55 PHOTOPHOBIA 2 0.0001
56 BLOOD URINE PRESENT 2 0.0001
57 PRESCRIBED OVERDOSE 2 0.0001
58 ORAL HERPES 2 0.0001
59 COMPLICATION OF DEVICE INSERTION 2 0.0001
60 BLINDNESS 4 0.0001
61 MENSTRUATION DELAYED 1 0.0001
62 OESOPHAGITIS 1 0.0001
63 EYE DISORDER 3 0.0001
64 SKIN INFECTION 1 0.0001
65 OCULAR DISCOMFORT 1 0.0001
66 PRESYNCOPE 2 0.0001
67 VISION BLURRED 11 0.0001
68 DYSARTHRIA 3 0.0001
69 MYDRIASIS 1 0.0001
70 DERMATITIS ATOPIC 4 0.0001
71 ADVERSE REACTION 1 0.0001
72 JAUNDICE 2 0.0001
73 MASS 1 0.0001
74 ACNE 5 0.0001
75 PRODUCT USE COMPLAINT 1 0.0001
76 PNEUMOTHORAX 1 0.0001
77 MIGRAINE 6 0.0001
78 CYSTITIS 2 0.0001
79 MOOD SWINGS 2 0.0001
80 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
81 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
82 EYE IRRITATION 3 0.0001
83 SEIZURE 6 0.0001
84 ERUCTATION 1 0.0001
85 SKIN FISSURES 1 0.0001
86 SYNCOPE 5 0.0000
87 PRODUCT PHYSICAL ISSUE 1 0.0000
88 POOR QUALITY SLEEP 1 0.0000
89 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
90 HEPATIC ENZYME INCREASED 3 0.0000
91 SKIN IRRITATION 2 0.0000
92 SKIN DISCOLOURATION 2 0.0000
93 FIBROMYALGIA 1 0.0000
94 AGEUSIA 1 0.0000
95 PNEUMONIA ASPIRATION 1 0.0000
96 HEPATITIS 1 0.0000
97 RESPIRATORY TRACT INFECTION 1 0.0000
98 HEADACHE 24 0.0000
99 NERVOUSNESS 2 0.0000
100 GASTRITIS 1 0.0000
101 PANCREATITIS 2 0.0000
102 DRY SKIN 5 0.0000
103 MENSTRUATION IRREGULAR 1 0.0000
104 BLOOD BILIRUBIN INCREASED 1 0.0000
105 RASH PRURITIC 2 0.0000
106 SKIN EXFOLIATION 3 0.0000
107 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
108 HYPERSOMNIA 1 0.0000
109 LABORATORY TEST ABNORMAL 1 0.0000
110 VERTIGO 2 0.0000
111 GYNAECOMASTIA 1 0.0000
112 NERVOUS SYSTEM DISORDER 1 0.0000
113 DRUG-INDUCED LIVER INJURY 1 0.0000
114 DYSPEPSIA 3 0.0000
115 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
116 EYE PRURITUS 1 0.0000
117 HAEMATURIA 1 0.0000
118 ERYTHEMA 6 0.0000
119 RASH MACULAR 1 0.0000
120 HEART RATE DECREASED 1 0.0000
121 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
122 CRYING 1 0.0000
123 PANIC ATTACK 1 0.0000
124 UNDERDOSE 2 0.0000
125 PRODUCT DOSE OMISSION ISSUE 8 0.0000
126 DYSURIA 1 0.0000
127 DYSGEUSIA 2 0.0000
128 DIZZINESS 13 0.0000
129 PALPITATIONS 3 0.0000
130 ABNORMAL BEHAVIOUR 1 0.0000
131 DRY MOUTH 2 0.0000
132 VISUAL IMPAIRMENT 3 0.0000
133 TREATMENT FAILURE 2 0.0000
134 POLLAKIURIA 1 0.0000
135 URTICARIA 4 0.0000
136 CONDITION AGGRAVATED 7 0.0000
137 DEVICE DISLOCATION 1 0.0000
138 MENTAL DISORDER 1 0.0000
139 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
140 BLOOD CHOLESTEROL INCREASED 1 0.0000
141 ANXIETY 6 0.0000
142 PRODUCTIVE COUGH 1 0.0000
143 RASH ERYTHEMATOUS 1 0.0000
144 PRURITUS 8 0.0000
145 RASH 9 0.0000
146 THERAPY CESSATION 1 0.0000
147 ILLNESS 2 0.0000
148 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
149 TREATMENT NONCOMPLIANCE 1 0.0000
150 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
151 ANAPHYLACTIC REACTION 1 0.0000
152 NECK PAIN 1 0.0000
153 ABDOMINAL DISCOMFORT 3 0.0000
154 EYE PAIN 1 0.0000
155 LETHARGY 1 0.0000
156 PRODUCT SUBSTITUTION ISSUE 1 0.0000
157 DECREASED APPETITE 4 0.0000
158 SURGERY 1 0.0000
159 THERAPEUTIC RESPONSE DECREASED 1 0.0000
160 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
161 DEVICE EXPULSION 1 0.0000
162 INFUSION RELATED REACTION 1 0.0000
163 INJECTION SITE PRURITUS 1 0.0000
164 PRODUCT QUALITY ISSUE 2 0.0000
165 ABDOMINAL PAIN UPPER 3 0.0000
166 BURNING SENSATION 1 0.0000
167 SLEEP DISORDER 1 0.0000
168 THERAPY INTERRUPTED 1 0.0000
169 SKIN BURNING SENSATION 1 0.0000
170 INFECTION 2 0.0000
171 AGITATION 1 0.0000
172 HYPOAESTHESIA 2 0.0000
173 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
174 CARDIAC ARREST 1 0.0000
175 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
176 COVID-19 2 0.0000
177 GASTROINTESTINAL DISORDER 1 0.0000
178 DEVICE ISSUE 1 0.0000
179 CHEST PAIN 2 0.0000
180 DRUG INEFFECTIVE 14 0.0000
181 PULMONARY EMBOLISM 1 0.0000
182 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
183 FLUSHING 1 0.0000
184 CHEST DISCOMFORT 1 0.0000
185 ABDOMINAL DISTENSION 1 0.0000
186 HYPERTENSION 2 0.0000
187 PNEUMONIA 3 0.0000
188 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
189 OFF LABEL USE 8 0.0000
190 FATIGUE 7 0.0000
191 INFLUENZA 1 0.0000
192 ASTHMA 1 0.0000
193 NAUSEA 7 0.0000
194 ABDOMINAL PAIN 2 0.0000
195 INJECTION SITE ERYTHEMA 1 0.0000
196 LOSS OF CONSCIOUSNESS 1 0.0000
197 WEIGHT DECREASED 2 0.0000
198 PAIN IN EXTREMITY 2 0.0000
199 BLOOD PRESSURE INCREASED 1 0.0000
200 INJECTION SITE PAIN 2 0.0000
201 PAIN 4 0.0000
202 VOMITING 3 0.0000
203 PARAESTHESIA 1 0.0000
204 TREMOR 1 0.0000
205 FALL 2 0.0000
206 MYALGIA 1 0.0000
207 URINARY TRACT INFECTION 1 0.0000
208 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
209 NO ADVERSE EVENT 1 0.0000
210 NASOPHARYNGITIS 1 0.0000
211 HYPERSENSITIVITY 1 0.0000
212 PRODUCT USE ISSUE 1 0.0000
213 DYSPNOEA 3 0.0000
214 ALOPECIA 1 0.0000
215 HYPOTENSION 1 0.0000
216 SOMNOLENCE 1 0.0000
217 CONSTIPATION 1 0.0000
218 WEIGHT INCREASED 1 0.0000
219 DEPRESSION 1 0.0000
220 INCORRECT DOSE ADMINISTERED 1 0.0000
221 FEELING ABNORMAL 1 0.0000
222 INSOMNIA 1 0.0000
223 DIARRHOEA 2 0.0000
224 ASTHENIA 1 0.0000
225 ARTHRALGIA 1 0.0000
226 DEATH 2 0.0000
227 MALAISE 1 0.0000